JAK2 and leukemia: Seven of these CRLF2R leukemias had concomitant activating mutations in JAK2. All eight CRLF2NR Ph-like leukemias had point mutations or rearrangements involving other kinases previously implicated in Ph-like ALL [15] (S1 Table).